Biomarker Trial of Everolimus in Patients With Advanced Renal Cell Carcinoma
Clinical trial NCT00827359 · COMPLETED
Trial details
- NCT number
- NCT00827359
- Sponsor
- Beth Israel Deaconess Medical Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-03-01
- Primary completion
- 2018-01-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.